Trial Profile
To evaluate safety and efficacy of intravesical incobotulinumtoxin A injections in patients with neurogenic bladder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Neurogenic bladder
- Focus Adverse reactions; Therapeutic Use
- 08 Jun 2017 New trial record
- 16 May 2017 Results presented at the 112th Annual Meeting of the American Urological Association